CalciMedica reported earnings of -$ 0.24 per CALC share on Nov 10, 2026, falling short of analysts' expectations by
| Report Date | Nov 10, 2026 |
|---|---|
| Forecasted EPS | -$ 1.27 |
| Earnings Per Share (Surprise) | -$ 0.24 (+$ 1.03) |
| Last Year's EPS | -$ 2.23 |
| EPS YoY Change |
Out of the last 32 earnings reporting periods, CalciMedica beat analysts’ expectations 12 times and fell short of expectations 13 time(s). CalciMedica reported earnings per share of -$ 0.24 in the last report surpassing an estimated EPS of -$ 1.27 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 1.27 | -$ 0.24 | -$ 3.40 | |
| Aug 11, 2026 | -$ 1.43 | -$ 2.25 | -$ 1.60 | |
| May 13, 2026 | -$ 1.40 | -$ 1.50 | -$ 2.60 | |
| May 12, 2026 | -$ 1.40 | -$ 1.10 | -$ 2.00 | |
| Mar 26, 2026 | -$ 2.75 | -$ 3.40 | -$ 2.00 | |
| Mar 3, 2026 | -$ 2.75 | -$ 1.60 | -$ 1.80 | |
| Nov 12, 2025 | -$ 2.06 | -$ 2.60 | -$ 0.34 | |
| Aug 12, 2025 | -$ 2.00 | -$ 2.00 | -$ 2.50 | |
| Aug 11, 2025 | -$ 2.00 | -$ 2.00 | -$ 1.80 | |
| May 14, 2025 | -$ 2.15 | -$ 1.80 | $ 0.05 | |
| Mar 27, 2025 | -$ 0.48 | -$ 0.34 | -$ 3.60 | |
| Nov 13, 2024 | -$ 2.50 | -$ 2.50 | -$ 4.05 | |
| Aug 12, 2024 | -$ 2.65 | -$ 1.80 | -$ 5.55 | |
| May 13, 2024 | -$ 3.35 | $ 0.05 | -$ 117.15 | |
| Mar 28, 2024 | -$ 4.35 | -$ 3.60 | $ 0.30 | |
| Nov 9, 2023 | -$ 5.70 | -$ 4.05 | -$ 32.20 | |
| Aug 10, 2023 | -$ 5.20 | -$ 5.55 | -$ 26.60 | |
| May 12, 2023 | -$ 3.65 | -$ 117.15 | -$ 33.60 | |
| Mar 9, 2023 | -$ 29.40 | $ 0.30 | -$ 28.70 | |
| Nov 10, 2022 | -$ 30.80 | -$ 32.20 | -$ 26.60 |
CalciMedica’s stock was trading at $ 1.52 on Nov 9, 2026 a day before the last earnings report was released.Following the release of the earnings report, CALC’s price decreased to $ 1.24 on Nov 11, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 10, 2026 | -$ 0.24 | $ 1.52 | $ 1.24 | |
| Aug 11, 2026 | -$ 2.25 | $ 3.30 | $ 3.10 | |
| May 13, 2026 | -$ 1.50 | $ 3.15 | $ 3.40 | |
| May 12, 2026 | -$ 1.10 | $ 2.96 | $ 3.45 | |
| Mar 26, 2026 | -$ 3.40 | $ 2.88 | $ 2.85 | |
| Mar 3, 2026 | -$ 1.60 | $ 2.54 | $ 3.12 | |
| Nov 12, 2025 | -$ 2.60 | $ 16.05 | $ 16.15 | |
| Aug 12, 2025 | -$ 2.00 | $ 13.80 | $ 11.85 | |
| Aug 11, 2025 | -$ 2.00 | $ 13.70 | $ 12.40 | |
| May 14, 2025 | -$ 1.80 | $ 9.65 | $ 9.70 | |
| Mar 27, 2025 | -$ 0.34 | $ 9.95 | $ 9.95 | |
| Nov 13, 2024 | -$ 2.50 | $ 17.45 | $ 16.85 | |
| Aug 12, 2024 | -$ 1.80 | $ 23.50 | $ 22.55 | |
| May 13, 2024 | $ 0.05 | $ 28.00 | $ 27.75 | |
| Mar 28, 2024 | -$ 3.60 | $ 20.95 | $ 19.65 | |
| Nov 9, 2023 | -$ 4.05 | $ 18.05 | $ 16.87 | |
| Aug 10, 2023 | -$ 5.55 | $ 17.20 | $ 16.34 |
CalciMedica released its most recent earnings reports in November 2026, August 2026, May 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
CalciMedica beat analysts’ expectations during the last earnings period by
